Insider Transactions Reported by 17 Insiders of LIGAND PHARMACEUTICALS INC

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Location
San Diego, CA

Insiders trading volume in the past year

LIGAND PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Todd C. Davis Chief Executive Officer, Director $32,143,170 +$1,000,456 +3.2% 04 Dec 2025
JOHN L. HIGGINS Director $30,203,525 28 Dec 2022
Jason Aryeh Director $16,237,863 -$1,708,088 -9.5% 08 Dec 2025
MATTHEW W. FOEHR Former Executive Officer $11,727,742 01 Nov 2022
JOHN W. KOZARICH Director $8,824,875 -$518,587 -5.6% 01 Dec 2025
JOHN L. LAMATTINA Director $6,312,245 -$858,576 -12% 07 Nov 2025
Matthew Korenberg President & COO $5,182,001 20 Sep 2024
Andrew Reardon CLO & Secretary $4,623,498 -$218,313 -4.5% 10 Aug 2025
Stephen L. Sabba Director $3,688,505 06 Jun 2025
Octavio Espinoza Chief Financial Officer $2,954,399 -$758,770 -20% 16 Dec 2025
Sunil Patel Former Director $2,083,974 01 Nov 2022
Charles S. Berkman Former Executive Officer $1,722,786 01 Nov 2022
Nancy Ryan Gray Director $1,662,912 -$1,350,012 -45% 07 Nov 2025
Martine Zimmermann Director $758,731 22 Sep 2025
Jason Haas Director $721,044 06 Jun 2025
Sarah Boyce Former Director $209,121 01 Nov 2022
Jennifer R. Cochran Former Director $83,952 01 Nov 2022

Recent Insider Transactions by Companies or Individuals for LIGAND PHARMACEUTICALS INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.